Cohort study to assess geographical variation in cholangiocarcinoma treatment in England
Sophie Jose(Insight Healthcare), Shahid A. Khan(Imperial College London), Amy Zalin‐Miller(National Health Service), Lizz Paley, Mireille B. Toledano(St Mary's Hospital), Helen Morement(CRUK Lung Cancer Centre of Excellence), Daniela Tataru(National Health Service), Craig Knott(Insight Healthcare)
Cited by 6
Related Papers
Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study
|The Lancet Oncology|2019|1.2k
Cholangiocarcinoma
|The Lancet|2005|1.1k
Changing international trends in mortality rates for liver, biliary and pancreatic tumours
|Journal of Hepatology|2002|592